# PerkinElmer to acquire Horizon Discovery Group for $383 million

PerkinElmer has agreed to acquire Horizon Discovery Group for approximately $383 million, adding gene editing and gene modulation tools to its life sciences portfolio.

- Type: Acquisition
- Announced: 2020-11-02
- Where: United Kingdom
- Value: $383.0M
- Status: announced
- Products: gene editing tools, gene modulation tools, cell engineering tools
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [PerkinElmer](https://endata.com/companies/20962.md) (acquirer)
- [Horizon Discovery Group](https://endata.com/companies/26707.md) (target)

## Sources

- [genengnews.com](https://www.genengnews.com/news/perkinelmer-adds-cell-engineering-tools-with-383m-horizon-acquisition/), 2020-11-02: "PerkinElmer has agreed to acquire Horizon Discovery Group for approximately $383 million, in a deal intended to add gene editing and gene modulation tools to the buyer’s portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.